Broad Institute Inc
415 Main St, Cambridge, MA · IRS data through FY2025
Revenue, expenses and net assets
Revenue Expenses Net assets
| Tax year | Revenue | Expenses | Net assets |
|---|---|---|---|
| FY2025 | $846,134,426 | $799,010,537 | $2,395,164,839 |
| FY2024 | $831,109,480 | $752,531,863 | $2,204,102,181 |
| FY2023 | $860,350,571 | $730,483,898 | $2,037,645,809 |
| FY2022 | $1,051,116,110 | $826,345,984 | $1,959,425,465 |
| FY2021 | $1,335,739,561 | $861,969,125 | $1,815,628,532 |
| FY2020 | $586,860,976 | $521,492,487 | $1,061,070,514 |
| FY2019 | $536,846,609 | $507,857,066 | $986,379,335 |
| FY2018 | $447,333,733 | $469,025,486 | $933,366,296 |
| FY2017 | $433,050,321 | $427,652,805 | $952,273,190 |
| FY2016 | $362,434,099 | $407,233,937 | $928,907,756 |
| FY2015 | $355,145,252 | $317,486,413 | $974,109,154 |
| FY2014 | $411,625,762 | $303,012,862 | $926,970,890 |
| FY2013 | $356,772,919 | $283,128,001 | $806,353,367 |
| FY2012 | $284,343,280 | $275,175,417 | $711,390,975 |
Form 990 filings
The returns filed by Broad Institute Inc (EIN 26-3428781), including Form 990 PDFs and e-file data by year, are available in ProPublica's Nonprofit Explorer. The figures on this page come from IRS data files built from those returns.
Where the revenue came from
| Source | Amount | % of revenue |
|---|---|---|
| Contributions & grants | $676,305,601 | 80% |
| Program service revenue | $67,090,286 | 8% |
| Other revenue | $102,738,539 | 12% |
Where the money was spent
| Category | Amount | % of expenses |
|---|---|---|
| Program services | $629,825,966 | 79% |
| Management & general | $164,960,011 | 21% |
| Fundraising | $4,224,560 | 1% |
What the numbers show
- Contributions & grants made up 80% of total revenue in FY2025.
- Program services accounted for 79% of functional expenses, management & general 21%, and fundraising 1%.
- 79% of functional expenses went to program services in FY2025. That is higher than 33.8% of 157 Medical Research organizations nationwide (too few in MA for a state comparison).
- Net assets covered about 36 months of expenses at the end of the reporting year. That puts it in the 60th percentile among 157 Medical Research organizations in MA.
- Total revenue was higher than 99.4% of 161 Medical Research organizations in MA.
- Total revenue rose from $284,343,280 in FY2012 to $846,134,426 in FY2025. Revenue increased in 9 and decreased in 4 of 13 year-over-year comparisons.
- Expenses exceeded revenue in 2 of 14 reported years (FY2016, FY2018).
- The highest revenue on record here is $1,335,739,561 in FY2021.
- Net assets grew from $711,390,975 to $2,395,164,839 between FY2012 and FY2025.
- Contributions and grants made up 95% of revenue in FY2012 and 80% in FY2025.
- Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity).
Figures compared against other organizations of the same NTEE program area in the same state. See the methodology page for how these are calculated and the guide to reading nonprofit financials for their limits.
About this organization
IRS status
| Ruling year | 2009 |
| Subsection | 501(c)(3) |
| Classification | Public charity |
| Program area (NTEE) | H20 — Medical Research |
| Donations | Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity). |
Similar organizations
- Whitehead Institute for Biomedical Research — Cambridge, MA · $222,267,487
- Dana Farber Mass General Brigham Cancer Care Inc — Boston, MA · $171,278,142
- Dana-Farber Cancer Institute — Boston, MA · $3,917,771,259
Source: Internal Revenue Service — Exempt Organizations Business Master File (downloaded November 4, 2026), Statistics of Income extracts, Form 990 e-file data, Publication 78 and the Automatic Revocation list. Figures are as reported by the organization; IRS processing may adjust them. This is not a charity rating and not tax advice. Confirm deductibility in IRS Tax Exempt Organization Search.
Think something here is wrong or should be removed? Use the contact form — we act on removal requests within 30 days.